Abstract:G protein-coupled receptors (GPCRs) as the most important class of pharmacological targets regulate G-protein and β-arrestin-mediated signaling through allosteric interplay, which are responsible for different biochemical and physiological actions like therapeutic efficacy and side effects. However, the allosteric mechanism underlying preferentially recruiting one transducer versus the other has been poorly understood, limiting drug design. Motivated by this issue, we utilize accelerated molecular dynamics simulation coupled with potential of mean force (PMF), molecular mechanics Poisson Boltzmann surface area (MM/PBSA) and protein structure network (PSN) to study two ternary complex systems of a representative class A GPCR (μ-opioid receptor (μOR)) bound by an agonist and one specific transducer (G-protein and β-arrestin). The results show that no significant difference exists in the whole structure of μOR between two transducer couplings, but displays transducer-dependent changes in the intracellular binding region of μOR, where the β-arrestin coupling results in a narrower crevice with TM7 inward movement compared with the G-protein. In addition, both the G-protein and β-arrestin coupling can increase the binding affinity of the agonist to the receptor. However, the interactions between the agonist and μOR also exhibit transducer-specific changes, in particular for the interaction with ECL2 that plays an important role in recruiting β-arrestin. The allosteric network analysis further indicates that Y1483.33, F1523.37, F1563.41, N1914.49, T1603.45, Y1062.42, W2936.48, F2896.44, I2485.54 and Y2525.58 play important roles in equally activating G-protein and β-arrestin. In contrast, M1613.46 and R1653.50 devote important contributions to preferentially recruit G-protein while D1643.49 and R179ICL2 are revealed to be important for selectively activating β-arrestin. The observations provide useful information for understanding the biased activation mechanism.

Molecular basis for allosteric agonism and G protein subtype selectivity of galanin receptors

Single Hormone or Synthetic Agonist Induces Gs/Gi Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths.

Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Ligand binding properties of human galanin receptors

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

Structure and dynamics determine G protein coupling specificity at a class A GPCR

Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs

Theoretical investigation of selective ligand binding mode of galanin receptors

Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions.

Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with G s proteins

Molecular basis for the selective G protein signaling of somatostatin receptors

Design of allosteric modulators that change GPCR G protein subtype selectivity

Molecular mechanism of agonism and inverse agonism in ghrelin receptor

Galanin, galanin receptors and drug targets

Allosteric Control of an Asymmetric Transduction in a G Protein-Coupled Receptor Heterodimer.

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.

Molecular Insights into the Allosteric Coupling Mechanism Between an Agonist and Two Different Transducers for Μ-Opioid Receptors.

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP